GlassScriptPhysician profile
Edward C Luan
NPI 1770596124
$2,549.26
in general payments reported to CMS, 2019-2025
18 companies · $325 in 2025
The $325 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $461 · 2020: $294 · 2021: $528 · 2022: $408 · 2023: $293 · 2024: $239 · 2025: $325.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $763 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $763.27 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $847.63 | 2019-2025 | |
| Astellas Pharma US INC | $493.09 | 2022-2025 | Veozah, Myrbetriq |
| Daiichi Sankyo INC. | $402.60 | 2019-2022 | |
| Exeltis, USA INC. | $213.89 | 2020-2025 | Slynd |
| Therapeuticsmd, INC. | $104.87 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $98.86 | 2021 | |
| Avion Pharmaceuticals | $88.93 | 2021-2022 | |
| Biogen, INC. | $77.28 | 2025 | Zurzuvae |
| Mayne Pharma Commercial LLC | $42.26 | 2025 | |
| Sumitomo Pharma America, INC. | $28.77 | 2024 | Myfembree |
| Lupin INC. | $28.58 | 2019-2020 | |
| Hologic Sales and Service, LLC | $24.48 | 2025 | Aptima |
| Biohaven Pharmaceutical Holding Company LTD. | $21.19 | 2022 | |
| Roche Diagnostics Corporation | $19.87 | 2019 | |
| Becton, Dickinson and Company | $17.50 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Minerva Surgical, INC | $14.77 | 2022 | |
| Evofem Biosciences, INC. | $12.63 | 2021 | |
| Renovia INC | $12.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Luan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.